Bismuth Subcitrate Potassium, Metronidazole And Tetracycline Hydrochloride Capsule
Product Images NDC 61269-386

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bismuth Subcitrate Potassium, Metronidazole And Tetracycline Hydrochloride (NDC 61269-386). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H2-pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

61269-386-12-blister (61269 386 12 Blister)

61269-386-12-blister (61269 386 12 Blister)
Label sheet for Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride capsules, each containing 140 mg, 125 mg, and 125 mg respectively. Each label indicates 3 capsules per blister, distributed by H2-Pharma, LLC, Montgomery, AL, with NDC 61269-386-12. Instructions note dosage as 3 capsules 4 times daily with reference to prescribing information. Labels include the Juvise Pharmaceuticals logo and barcode.*
FDA Label Image

61269-386-12-carton (61269 386 12 Carton)

61269-386-12-carton (61269 386 12 Carton)
Packaging label for Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride Capsules 140 mg/125 mg/125 mg by H2-Pharma, LLC. The label states this is a 10 Day Therapy PAK containing 120 capsules in 10 blister cards, each card with 4 blisters and each blister with 3 capsules. The label includes dosing schedule details, storage instructions, and identification of the capsules with BMT printed on the cap. The product is made in France and distributed by H2-Pharma, LLC in Montgomery, AL.*
FDA Label Image

Metronidazole (Metronidazole)

Metronidazole (Metronidazole)
Chemical structure diagram of the active ingredient in the product Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride. The diagram shows the molecular arrangement of atoms and bonds typical for this compound class.*
FDA Label Image

Tetracycline Hydrochloride (Tetracycline Hydrochloride)

Tetracycline Hydrochloride (Tetracycline Hydrochloride)
Chemical structure of Tetracycline Hydrochloride, an active ingredient in Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride capsules, displayed as a multi-ring molecular diagram with hydroxyl, methyl, amine, and ketone functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.